Gene Symbol | B2M |
Entrez ID | 567 |
Uniprot ID | P61769 |
Description | beta-2-microglobulin |
Chromosomal Location | chr15: 44,711,477-44,718,877 |
Ontology | GO ID | GO Term | Definition | Evidence |
---|---|---|---|---|
BP |
GO:0001895 |
retina homeostasis |
A tissue homeostatic process involved in the maintenance of an internal equilibrium within the retina of the eye, including control of cellular proliferation and death and control of metabolic function. |
IEP |
BP |
GO:0001916 |
positive regulation of T cell mediated cytotoxicity |
Any process that activates or increases the frequency, rate or extent of T cell mediated cytotoxicity. |
IEA |
BP |
GO:0002474 |
antigen processing and presentation of peptide antigen via MHC class I |
The process in which an antigen-presenting cell expresses a peptide antigen on its cell surface in association with an MHC class I protein complex. Class I here refers to classical class I molecules. |
TAS |
BP |
GO:0002479 |
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent |
The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class I protein complex following intracellular transport via a TAP (transporter associated with antigen processing) pathway. The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell and is dependent on TAP transport from the cytosol to ER for association with the MHC class I molecule. Class I here refers to classical class I molecules. |
TAS |
BP |
GO:0002480 |
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent |
The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class I protein complex following intracellular transport via a pathway not requiring TAP (transporter associated with antigen processing). The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell. Class I here refers to classical class I molecules. |
TAS |
BP |
GO:0002481 |
antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent |
The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class Ib protein complex following intracellular transport via a TAP (transporter associated with antigen processing) pathway. The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell and is dependent on TAP transport from the cytosol to ER for association with the MHC class Ib molecule. Class Ib here refers to non-classical class I molecules, such as those of the HLA-E gene family. |
IEA |
BP |
GO:0002726 |
positive regulation of T cell cytokine production |
Any process that activates or increases the frequency, rate, or extent of T cell cytokine production. |
IDA |
BP |
GO:0003254 |
regulation of membrane depolarization |
Any process that modulates the rate, frequency or extent of membrane depolarization. Membrane depolarization is the process in which membrane potential changes in the depolarizing direction from the resting potential, usually from negative to positive. |
IDA |
BP |
GO:0010977 |
negative regulation of neuron projection development |
Any process that decreases the rate, frequency or extent of neuron projection development. Neuron projection development is the process whose specific outcome is the progression of a neuron projection over time, from its formation to the mature structure. A neuron projection is any process extending from a neural cell, such as axons or dendrites (collectively called neurites). |
IEA |
BP |
GO:0019731 |
antibacterial humoral response |
An immune response against bacteria mediated through a body fluid. Examples of this process are the antibacterial humoral responses in Mus musculus and Drosophila melanogaster. |
IDA |
BP |
GO:0019885 |
antigen processing and presentation of endogenous peptide antigen via MHC class I |
The process in which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class I protein complex. The peptide antigen is typically, but not always, processed from a whole protein. Class I here refers to classical class I molecules. |
IGI |
BP |
GO:0032092 |
positive regulation of protein binding |
Any process that activates or increases the frequency, rate or extent of protein binding. |
IGI |
BP |
GO:0033077 |
T cell differentiation in thymus |
The process in which a precursor cell type acquires the specialized features of a T cell via a differentiation pathway dependent upon transit through the thymus. |
IEA |
BP |
GO:0042026 |
protein refolding |
The process carried out by a cell that restores the biological activity of an unfolded or misfolded protein, using helper proteins such as chaperones. |
IEA |
BP |
GO:0042493 |
response to drug |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease. |
IEA |
BP |
GO:0044267 |
cellular protein metabolic process |
The chemical reactions and pathways involving a specific protein, rather than of proteins in general, occurring at the level of an individual cell. Includes cellular protein modification. |
TAS |
BP |
GO:0045087 |
innate immune response |
Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens. |
IDA|TAS |
BP |
GO:0046686 |
response to cadmium ion |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cadmium (Cd) ion stimulus. |
IEA |
BP |
GO:0048260 |
positive regulation of receptor-mediated endocytosis |
Any process that activates or increases the frequency, rate or extent of receptor mediated endocytosis, the uptake of external materials by cells, utilizing receptors to ensure specificity of transport. |
IGI |
BP |
GO:0050690 |
regulation of defense response to virus by virus |
Any viral process that modulates the frequency, rate, or extent of the antiviral response of the host cell or organism. |
TAS |
BP |
GO:0050776 |
regulation of immune response |
Any process that modulates the frequency, rate or extent of the immune response, the immunological reaction of an organism to an immunogenic stimulus. |
TAS |
BP |
GO:0050829 |
defense response to Gram-negative bacterium |
Reactions triggered in response to the presence of a Gram-negative bacterium that act to protect the cell or organism. |
IDA |
BP |
GO:0050830 |
defense response to Gram-positive bacterium |
Reactions triggered in response to the presence of a Gram-positive bacterium that act to protect the cell or organism. |
IDA |
BP |
GO:0055072 |
iron ion homeostasis |
Any process involved in the maintenance of an internal steady state of iron ions within an organism or cell. |
IC |
BP |
GO:0060333 |
interferon-gamma-mediated signaling pathway |
A series of molecular signals initiated by the binding of interferon-gamma to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription. Interferon gamma is the only member of the type II interferon found so far. |
TAS |
BP |
GO:0071222 |
cellular response to lipopolysaccharide |
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria. |
IDA |
BP |
GO:0071281 |
cellular response to iron ion |
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an iron ion stimulus. |
IGI |
BP |
GO:1900121 |
negative regulation of receptor binding |
Any process that stops, prevents or reduces the frequency, rate or extent of a protein or other molecule binding to a receptor. |
IDA |
BP |
GO:1900122 |
positive regulation of receptor binding |
Any process that activates or increases the frequency, rate or extent of a protein or other molecule binding to a receptor. |
IGI |
BP |
GO:1903991 |
positive regulation of ferrous iron import into cell |
Any process that activates or increases the frequency, rate or extent of ferrous iron import into cell. |
IGI |
BP |
GO:1904434 |
positive regulation of ferrous iron binding |
Any process that activates or increases the frequency, rate or extent of ferrous iron binding. |
IGI |
BP |
GO:1904437 |
positive regulation of transferrin receptor binding |
Any process that activates or increases the frequency, rate or extent of transferrin receptor binding. |
IGI |
CC |
GO:0000139 |
Golgi membrane |
The lipid bilayer surrounding any of the compartments of the Golgi apparatus. |
TAS |
CC |
GO:0005576 |
extracellular region |
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite. |
TAS |
CC |
GO:0005615 |
extracellular space |
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid. |
IDA |
CC |
GO:0005737 |
cytoplasm |
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
IDA |
CC |
GO:0005788 |
endoplasmic reticulum lumen |
The volume enclosed by the membranes of the endoplasmic reticulum. |
TAS |
CC |
GO:0005794 |
Golgi apparatus |
A compound membranous cytoplasmic organelle of eukaryotic cells, consisting of flattened, ribosome-free vesicles arranged in a more or less regular stack. The Golgi apparatus differs from the endoplasmic reticulum in often having slightly thicker membranes, appearing in sections as a characteristic shallow semicircle so that the convex side (cis or entry face) abuts the endoplasmic reticulum, secretory vesicles emerging from the concave side (trans or exit face). In vertebrate cells there is usually one such organelle, while in invertebrates and plants, where they are known usually as dictyosomes, there may be several scattered in the cytoplasm. The Golgi apparatus processes proteins produced on the ribosomes of the rough endoplasmic reticulum; such processing includes modification of the core oligosaccharides of glycoproteins, and the sorting and packaging of proteins for transport to a variety of cellular locations. Three different regions of the Golgi are now recognized both in terms of structure and function: cis, in the vicinity of the cis face, trans, in the vicinity of the trans face, and medial, lying between the cis and trans regions. |
IDA |
CC |
GO:0005886 |
plasma membrane |
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
IDA|TAS |
CC |
GO:0005925 |
focal adhesion |
Small region on the surface of a cell that anchors the cell to the extracellular matrix and that forms a point of termination of actin filaments. |
IDA |
CC |
GO:0009897 |
external side of plasma membrane |
The leaflet of the plasma membrane that faces away from the cytoplasm and any proteins embedded or anchored in it or attached to its surface. |
IEA |
CC |
GO:0012507 |
ER to Golgi transport vesicle membrane |
The lipid bilayer surrounding a vesicle transporting substances from the endoplasmic reticulum to the Golgi. |
TAS |
CC |
GO:0016020 |
membrane |
A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it. |
IDA |
CC |
GO:0030670 |
phagocytic vesicle membrane |
The lipid bilayer surrounding a phagocytic vesicle. |
TAS |
CC |
GO:0031901 |
early endosome membrane |
The lipid bilayer surrounding an early endosome. |
TAS |
CC |
GO:0031905 |
early endosome lumen |
The volume enclosed by the membrane of an early endosome. |
TAS |
CC |
GO:0042612 |
MHC class I protein complex |
A transmembrane protein complex composed of a MHC class I alpha chain and an invariant beta2-microglobin chain, and with or without a bound peptide antigen. Class I here refers to classical class I molecules. |
IEA |
CC |
GO:0070062 |
extracellular exosome |
A membrane-bounded vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm. |
IDA |
CC |
GO:1990712 |
HFE-transferrin receptor complex |
A protein complex containing at least HFE and a transferrin receptor (either TFR1/TFRC or TFR2), proposed to play a role in the sensing of transferrin-bound Fe (Fe2-Tf) on the plasma membrane to regulate hepcidin transcription. |
IDA |
MF |
GO:0001948 |
glycoprotein binding |
Interacting selectively and non-covalently with a glycoprotein, a protein that contains covalently bound glycose (monosaccharide) residues. These also include proteoglycans. |
IPI |
MF |
GO:0005515 |
protein binding |
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
IPI |
MF |
GO:0042802 |
identical protein binding |
Interacting selectively and non-covalently with an identical protein or proteins. |
IPI |
Domain ID | Description |
---|---|
IPR003006 |
Immunoglobulin/major histocompatibility complex, conserved site |
IPR003597 |
Immunoglobulin C1-set |
IPR007110 |
Immunoglobulin-like domain |
IPR013783 |
Immunoglobulin-like fold |
IPR015707 |
Beta-2-Microglobulin |
Pathway ID | Pathway Term | Pathway Source |
---|---|---|
hsa04612 |
Antigen processing and presentation |
KEGG |
h_mhcPathway |
Antigen Processing and Presentation |
BioCarta |
h_ctlPathway |
CTL mediated immune response against target cells |
BioCarta |
h_nkcellsPathway |
Ras-Independent pathway in NK cell-mediated cytotoxicity |
BioCarta |
UMLS CUI | UMLS Term |
---|---|
C0004364 |
Autoimmune Diseases |
C0018799 |
Heart Diseases |
C0020455 |
Hypergammaglobulinemia |
C0022658 |
Kidney Diseases |
C0033578 |
Prostatic Neoplasms |
C0079744 |
Diffuse Large B-Cell Lymphoma |
C0079774 |
Peripheral T-Cell Lymphoma |
C2609414 |
Acute Kidney Injury |
Tissue | Cell Type |
---|---|
bone marrow |
hematopoietic cells |
bronchus |
respiratory epithelial cells |
lung |
macrophages |
lung |
pneumocytes |
lymph node |
germinal center cells |
lymph node |
non-germinal center cells |
nasopharynx |
respiratory epithelial cells |
spleen |
cells in white pulp |
tonsil |
germinal center cells |
tonsil |
non-germinal center cells |
tonsil |
squamous epithelial cells |
Pubmed ID | Author | Year | Title |
---|---|---|---|
22951915 |
Haozi et al. |
2012 |
Altered gene expression profile in cumulus cells of mature MII oocytes from patients with polycystic ovary syndrome |
Gene Symbol | Entrez ID | Uniprot ID | Score |
---|---|---|---|
HLA-B |
3106 |
P30481 |
0.23 |
VCL |
7414 |
P18206 |
0.49 |
CD8A |
925 |
P01732 |
0.52 |
CRYAB |
1410 |
P02511 |
0.56 |
RPL6 |
6128 |
Q02878 |
0.63 |
TAPBP |
6892 |
O15533 |
0.63 |
BAG6 |
7917 |
P46379 |
0.63 |
PRSS23 |
11098 |
O95084 |
0.63 |
CALR |
811 |
P27797 |
0.65 |
HLA-A |
3105 |
P01891 |
0.72 |
PCOLCE |
5118 |
Q15113 |
0.72 |
TFRC |
7037 |
P02786 |
0.72 |
A2M |
2 |
P01023 |
0.75 |
HLA-A |
3105 |
P01892 |
0.82 |
HLA-B |
3106 |
P03989 |
0.82 |
B2M |
567 |
P61769 |
0.90 |
HLA-B |
3106 |
P30460 |
0.23 |
CD1E |
913 |
P15812 |
0.52 |
CXCR4 |
7852 |
P61073 |
0.56 |
HLA-G |
3135 |
P17693 |
0.62 |
LILRB1 |
10859 |
Q8NHL6 |
0.62 |
ERBB3 |
2065 |
P21860 |
0.63 |
GRB2 |
2885 |
P62993 |
0.63 |
HSPB2 |
3316 |
Q16082 |
0.63 |
TAP2 |
6891 |
Q03519 |
0.63 |
KIAA0101 |
9768 |
Q15004 |
0.63 |
LIN37 |
55957 |
Q96GY3 |
0.63 |
LIN54 |
132660 |
Q6MZP7 |
0.63 |
HLA-B |
3106 |
P18464 |
0.72 |
HLA-B |
3106 |
P30491 |
0.72 |
HLA-B |
3106 |
P30685 |
0.72 |
HLA-C |
3107 |
P30504 |
0.72 |
MAP1S |
55201 |
Q66K74 |
0.72 |
MAPK15 |
225689 |
Q8TD08 |
0.72 |
HLA-F |
3134 |
P30511 |
0.75 |
HLA-C |
3107 |
P30499 |
0.76 |
HLA-A |
3105 |
P30443 |
0.82 |
CD1A |
909 |
P06126 |
0.84 |
TAP1 |
6890 |
Q03518 |
0.86 |
CD1B |
910 |
P29016 |
0.88 |
HLA-B |
3106 |
P01889 |
0.88 |
FCGRT |
2217 |
P55899 |
0.89 |
HLA-E |
3133 |
P13747 |
0.89 |
HFE |
3077 |
Q30201 |
0.90 |
CD1D |
912 |
P15813 |
0.91 |